Table 3.

Effects of CD30 triggering on L540 cell proliferation

L540 cell treatment3-150Cycling cells,3-151 %Living cells,3-151 %
M67 63 ± 1.83-152 81 ± 10 
BerH2 96 ± 2.1 84 ± 6  
PMA + ionomycin 87 ± 8.4 94 ± 5 
L540 cell treatment3-150Cycling cells,3-151 %Living cells,3-151 %
M67 63 ± 1.83-152 81 ± 10 
BerH2 96 ± 2.1 84 ± 6  
PMA + ionomycin 87 ± 8.4 94 ± 5 

Values are mean ± SD of 5 experiments.

F3-150

10 μg/mL plastic-bound mAb M44, M67, or BerH2; 15 ng/mL PMA + 500 ng/mL ionomycin.

F3-151

Normalized to the corresponding percentage for untreated L540 cells.

F3-152

P = .001 compared with untreated L540 cells.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal